Quantcast
Last updated on April 20, 2014 at 21:20 EDT

Latest James Shapiro Stories

2012-07-19 10:22:58

SAN DIEGO and EDMONTON, Alberta, July 19, 2012 /PRNewswire/ -- Conatus Pharmaceuticals Inc. and the University of Alberta announced today the treatment of the first patient in an investigator-initiated islet cell transplant Phase I/II trial of emricasan (IDN-6556), a pan-caspase inhibitor. The objective of the trial is to determine safety, achievement and maintenance of insulin independence and to obtain preliminary data on the efficacy of emricasan to maintain adequate immunological...

2012-03-27 02:27:04

NEW YORK, March 27, 2012 /PRNewswire/ -- Islet Sciences, Inc., (OTC.BB: ISLT) a biotechnology company engaged in the research, development and commercialization of patented technologies in the field of transplantation therapy for patients with diabetes, today named six inaugural members to its Scientific Advisory Board: Dr. Paul Johnson, Dr. Jonathan Lakey, Dr. Steven Paraskevas, Dr. Miguel Riella, Dr. Christian Mende and Dr. Jerry Nadler. "Clearly this esteemed group of Doctors will be...